Insmed Analyst Ratings
TD Cowen Sticks to Its Buy Rating for Insmed (INSM)
HealthEquity Analyst Ratings
Maintaining Buy Rating on Healthequity Amid Limited Impact Security Incident
Sprouts Farmers Market Analyst Ratings
Fluor Analyst Ratings
Optimistic Buy Rating for Insmed's Brensocatib Based on Forthcoming ASPEN Data and Competitive Analysis
Beyond the Efficient Frontier With SynthEquity - Using Call Options to Modernize MPT
TD Cowen Remains a Buy on Vaxcyte (PCVX)
Insmed Analyst Ratings
Sprouts Farmers Market Analyst Ratings
Vaxcyte Analyst Ratings
Navigating 4 Analyst Ratings For Fabrinet
Fabrinet Analyst Ratings
Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating
Vaxcyte Analyst Ratings
Sprouts Farmers Market Analyst Ratings
Evercore ISI Group Maintains In-Line on Sprouts Farmers Market, Raises Price Target to $75
Insmed Analyst Ratings
HealthEquity Analyst Ratings